Metastatic Castration-Resistant Prostate Carcinoma
13 clinical trials · Condition
◉ Watch Metastatic Castration-Resistant Prostate Carcinoma
| Record | Firm | Date |
|---|---|---|
| Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer (NCT05113537) | Vadim S Koshkin | 2022-07-08 |
| An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer (NCT04777071) | University of Washington | 2021-05-17 |
| Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy (NCT04071236) | National Cancer Institute (NCI) | 2020-10-14 |
| Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity (NCT01621425) | Radboud University Medical Center | 2012-06-01 |
Track Metastatic Castration-Resistant Prostate Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.